Upload
others
View
3
Download
0
Embed Size (px)
Citation preview
1
Memy H. Hassan, PhD Associate Professor of
Pharmacology &Toxicology
College of Pharmacy,
Taibah University
Dina S. El-Agamy, PhD Associate Professor of
Pharmacology &Toxicology
College of Pharmacy,
Taibah University
Lecture ILOs • To outline the basic scientific terms of hypertension and
different management options
• To understand the action of drugs on cardiac and vascular
smooth muscle
• Topics covered in this lecture 1. Snapshot overview about hypertension
2. Characters of ideal antihypertensive drugs
3. Pharmacological principles in the treatment of hypertension
4. Classes of antihypertensive drugs.
5. Mode of action and beneficial effects of different antihypertensive drugs
6. Main uses, main adverse effects and main drug interactions of antihypertensive
drugs
7. Choice of antihypertensive drug in different disease conditions
07/03/2016 2
3
Remember
Snapshots about hypertension
Def.: HTN is a sustained elevation of blood pressure: – Systolic BP 140 mm Hg
– Diastolic BP 90 mm Hg.
When drug therapy is indicated?
• If the diastolic pressure 90 mm Hg.
HTN Risk Factors A) Influenceable factors: Cigarette smoking; Elevated LDL; Stress;
Obesity; Increased Na intake.
B) Non- Influenceable factors: Family history; Insulin resistance (DM); Age
Signs & Symptoms – Usually NO SYMPTOMS!
– “The Silent Killer”
– May have: Headache; Blurry vision; Chest Pain; Frequent urination at night
• Confirmed by Blood Pressure Measurement
07/03/2016 4
Category
• Normal
• High normal (Prehypertension)
Hypertension (old classes))
• Stage 1 (mild)
• Stage 2 (moderate)
• Stage 3*** (severe)
• Stage 4*** (Malignant)*
Systolic** Diastolic
<130 <85
139 89
140-159 90-99
160-179 100-109
180-209 110-119
>210 >120
Remember
Classification of HTN
1. According to the degree of rise in BP
07/03/2016 5
Hypertension
Essential (primary) HTN - in 90-95 % & of unknown cause.
- Predisposing factors are risk
factors.
Secondary HTN (in 5-10 %)
due to: a) Pathological defect: e.g., Renal
artery stenosis & Coarctation of
the aorta.
b) Hormonal defects: Cushing´s
syndrome, phaeochromocytoma.
c) Physiological defects: e.g.,
HTN with pregnancy
d) Drug-induced HTN:
(sympatomimetics,
glucocorticoids)
Remember
2. Classification of HTN According to Etiology
07/03/2016 7
THERAPY OF HYPERTENSION
A) Non-pharmacological Approaches
1. Salt intake:
2. Body weight:
3. Cessation of smoking or alcohol drinking.
4. Regular physical activity and relaxation.
6. Stress avoidance (both physical & mental).
7. Intake K+:
8. Coffee restriction:
B) Pharmacotherapy using antihypertensive drugs which are classified
according to the mode of action
1. Diuretics.
2. Sympatholytics.
3. Direct Vasodilators.
4. Calcium channel blockers.
5. Drugs that interfere with Renin Angiotensin System (RAS).
Characters of ideal antihypertensive drug
1) Effectively reduce BP
2) Taken once daily
3) No serous side effects or at least acceptable profile
4) Produce 24 h control
5) Reduce HTN- induced complications
6) Shows predictable dose-effect relationship
07/03/2016 8
9
Mode of hypotensive action: • Diuretic effects (Depletion of the sodium and water) blood
volume and cardiac output.
• Vasodilator effects PR (with thiazides)
i- Thiazides and related drugs Chlortalidone, Hydrochlorothizide & Indapamide, etc. Most frequently used diuretics in HTN. More effective as hypotensive drugs than loop diuretics. In severe HTN, used in combination with other drugs (ACEIs or ARBs). Not useful in HTN patients with renal impairment. Mechanism of hypotensive action of thiazides
a) Initially: blood volume by diuretic effects CO. b) Later on: VD effect PVR
Side effects:
HYPO: tension, kalaemic metabolic alkalosis , magnesaemia, natraemia,
erection………………. HYPER: glycaemia , uricaemia, calcaemia
07/03/2016 10
ii- LOOP DIURETICS
e.g., Furosemid, ethacrynic acid, bumetanide & torsemide.
Used in: - Severe HTN.
- HTN patients with renal impairment.
- HTN Patients with left sided HF &/or pulmonary oedema.
- HTN not responded to thiazide diuretics
- HTN emergency. Rapid onset & short duration (4 hours) .
- Less antihypertensive efficacy than thiazides (due to short duration).
Mechanism of hypotensive action:
a) Diuretic effect blood volume CO.
b) Venodilation venous return CO.
Side effects
similar to thiazide except it produces hypocalcemia,
ototoxicity and Idiosyncratic allergic reactions
11
iii- K-sparing Diuretics
1. Spironolactone (Aldactone):
– Lower BP by its diuretic effect ( plasma
volume).
– Aldosterone receptor blocker
– Used in:
• HTN due to hyperaldosteronism.
• Combination with K-depleting drugs
• Combination with digitalis & thiazides in HF.
2. Amiloride & triamterene: • Useful in combination with K-depleting drugs.
• Blocking lumenal sodium channels
Drugs interfering with Renin-angiotensin System
Beta-blocker -
--
A- Angiotensin converting enzyme inhibitors (ACEIs)
Types of ACEIs
1. Active molecules: Captopril, Lisinopril, Enalaprilat
2. Prodrugs: Enalapril, Benazepril, Fosinopril, Quinapril, Ramipril.
Mechanism of Action: Inhibition of angiotensin II formation leading to:
a- Beneficial effect
1-Reduction in systemic arteriolar resistance, systolic, diastolic and mean
arterial pressure.
2- Regional hemodynamic effects:
– Increased regional blood flow & large artery compliance
3- Decreased aldosterone secretion
B- Bad effect: accumulation of bradykinin causing dry cough sometimes
accompanied by wheezing, and angioedema
Effect of ACEIs on blood pressure
i- Favorable side effects: tolerated by most patient.
ii- Beneficial for diabetics : renoprotective in diabetic nephropathy.
iii- Beneficial in HTN with heart failure: 1st choice.
iv- Beneficial if used Post MI: morbidity& improve ventricular function.
v- Do not cause sexual dysfunction: (unlike diuretics & sympatholytics).
vi- Do not cause postural hypotension. (unlike α blocker &direct vasodilators)
vii- Do not produce serious metabolic alterations: no hypokalemia, no
hyperglycemia, no hyperlipidemia.
Advantages of ACEIs
07/03/2016 15
Uses of ACEIs
1. Hypertension: stages 1- 4 HTN
2. Heart failure: 1st choice.
3. Acute MI:
– Started immediately during the acute phase
of MI.
– Administered along with thrombolytics,
aspirin, and BBs).
1. Diabetic & non-diabetic nephropathy:
– Renoprotective: because of intrrenal
hypertension or growth factor formation.
ADRs of ACEIs 1. S-H related adverse effect:
– Allergic reactions: edema, rash and neutropenia ( # Use other ACEIs).
– Dysgeusia: temporary loss of taste. (# Use other ACEIs).
– Drug (e.g., antacids) and food interactions (reduce absorption of captopril # by giving before meal
2. Class adverse effects: – Hypotension : after 1st dose in Na+ depleted patients by diuretics # stop diuretics before
administration.
– Dry cough and loss of smell: due to accumulation of bradykinin & PGs
– Hyperkalemia: (due to aldosteron) # by HTZ (e.g., capozid).
– Fetopathic Potential: fetal hypotension , fetal growth retardation & fetal death if given during 2nd or 3rd trimesters.
– Acute renal failure: In patients with bilateral renal artery stenosis # C/I in bilateral artery stenosis
– Angioedema: rapid swelling in the nose, throat, mouth, glottis, larynx, lips, and/or tongue
due to change in bradykinin metabolism
– Proteinuria……..in patients with compromised renal function.
07/03/2016 17
B) BLOCKERS OF AT1 RECEPTOR
Members:
Losartan , Candesartan, Irbesartan, Valsartan, Telmisartan, Eprosartan
Thiazide-combinations: Losartan + HTZ, Candesartan + HTZ & Valsartan
+ HTZ
Mode of action
Competitive antagonists of angiotensin II :
• Relax smooth muscle VD
• renal salt and water excretion
• Reduce plasma volume
• Decrease cellular hypertrophy antiremodeling
BP
Advantages of AIIRBs over ACEIs
• Prevent accumulation of bradykinin and PGs.
• Free from dry cough caused by ACEIs
Uses: as ACEIs:
Mild-severe HTN; Post MI; HF
Diabetic nephropathy.
07/03/2016 18
Sympatholytics
a) -Adrenergic blockers: e.g., propranolol,
metoprolol, etc.
b) - Adrenergic blockers: e.g., prazosin,
phenoxybenzamine, etc.
c) Mixed adrenergic antagonists: e.g., labetalol &
carvedilol.
d) Adrenergic neuron blockers: e.g., reserpine,
guanethidine & guanadrel.
e) Ganglion blockers: e.g., trimethaphan.
f) Centrally acting: e.g., clonidine, -methylopa.
19
1. - Adrenergic Receptor Antagonists
• First generation (non-selective β blockers): e.g., Propranolol, Nadolol, Sotalol and Timolol
• Second gereation ( β1-Selective β blockers): e.g., e.g., Acebutolol, Atenolol, Bisoprolol, Esmolol & Metoprolol
Mechanism of Hypotensive Action of -Blockers
1. Decreased cardiac output.
2. Inhibition of renin secretion from the kidneys.
3. Decreased central sympathetic outflow.
4. Blocking presynaptic 2-receptors → NEP release.
Therapeutic Uses of - blockers in HTN
1. Used for all grades of HTN.
2. All are preferred in HTN concomitant with:
– SVT, previous MI, IHD, chronic HF, and migraine headache.
3. β1-Selective β blockers are preferred in asthmatics & diabetics-why?
20
2. 1 - Adrenergic Antagonists
e.g. Prazosin; doxazosin; Terazosin
produce a competitive block of ɑ1-adrenoceptors.
– VD of artery & arterioles PVR diastolic BP.
– VD of veins & venules venous return CO systolic
BP (not significant).
Tamsulosin, an ɑ1a- blocker with greater selectivity for prostate muscle, has been used in the treatment of prostate hyperplasia.
Therapeutic Uses of 1 -blockers
• Attractive drugs for HTN patients with BPH–why?
– improve both urinary & BP symptoms.
ADRs of 1 - Adrenergic Antagonists
1. First-dose Phenomena. Orthostatic hypotension (given at bed time); Syncopal
attacks and fall
2. Palpitation & tachycardia
3. GI upset
07/03/2016 21
3. Mixed 1 and - receptor antagonists
1. Labetalol (TRANDATE) • Used in hypertensive emergencies; I.V. labetalol
BP sufficiently & rapidly.
• Blocking 1-adrenergic receptors & -receptors.
2. Carvedilol (COREG):
• Used in HTN with symptomatic HF:
– It reduces mortality in patients with HF why?
Because of VD & anti-remodeling effect.
22
4. Central sympatholytics
a) - Methyldopa (ALDOMET): – Commonly used in HTN with pregnancy- why?
• Due to its efficacy and safety for both mother and fetus.
– Centrally acting antihypertensive agent- How?
- Methyldopa (prodrug) active metabolite -methylnorepinephrine :
• Central 2-agonist central sympathetic outflow.
• Peripherally released as false transmitter.
ADRs of -Methydopa 1. Central ADRs related to pharmacological actions:
Sedation; Psychic depression: due to depletion of catecholamines in CNS; Dryness of the mouth; Reduction in libido & impotence: due to sympatholytic action in the CNS; Parkinsonian signs: due to dopamine depletion in basal ganglia; Hyperprolactinemia gynecomastia and galactorrhea.
ii) Rare ADRs; immunological reactions:
1) Hepatotoxicity associated with fever. 2) Hemolytic anemia.
3) leukopenia, thrombocytopenia, red cell aplasia,
07/03/2016 23
b) Direct central 2-agonist:
Members:
• Clonidine (CATAPRES); Guanabenz (WYTENSIN); Guanfacine (TENEX)
Mechanism of action:
• Central 2 (2A) receptor agonists (in brainstem) sympathetic
outflow from the CNS BP (both CO & PVR).
• High doses peripherally stimulate postsynaptic 2 receptor VC
BP.
Uses of Clonidine (2006) Not commonly used in TTT of HTN.
• Clonidine is used in hypertensive patients for the diagnosis of
pheochromocytoma
• Clonidine is used in management of opioid withdrawal
07/03/2016 24
CALCIUM CHANNEL-BLOCKERS
1. Dihydropyridine derivatives: 1. Nifedipine
2. Amlodipine 3. Isradipine
4. Nicardipine
5. Felodipine
– VD with reflex tachycardia.
2. Non-dihydropyridine: Diltiazem (DILZIUM)
Verapamil (ISOPTIN)
– VD with –ve chronotropic & -ve inotropic effects.
Blocking Ca2+ channels (L-type voltage-sensitive type) Ca2+
intracellularly
Relaxation of the arterial smooth muscle but not much effect on venous
smooth muscle → Significant reduction in afterload but not preload.
Myocardial depressant effect by only verapamil and diltiazem CO.
Inhibiting phosphodiesterase enzymes cAMP VD PVR.
Cardiovascular Uses of CCBs
Angina pectoris
Hypertension
Supraventricular arrhythmias (verapamil & Diltiazem only)
- Atrial Flutter
- Atrial Fibrillation
- Paroxysmal SVT
CCBs – Mechanisms of Action ( COP and TPR)
According to route of administration
Oral Vasodilators Hydralazine & Minoxidil
Parenteral Vasodilators Diazoxide & Sodium nitroprusside
(Used in emergency(
Direct Vasodilators
Direct Vasodilators according to site of action
Arteriodilators Hydralazine & Minoxidil and
Diazoxide
Mixed Vasodilators Sodium nitroprusside
Vasodilators
• They dilate blood vessels by acting directly on
smooth muscle cells through non-autonomic
• Major mechanisms for direct vasodilators
– Release of nitric oxide e.g. sodium nitroproside
– Opening of potassium channels e.g. Minoxidil,
Diazoxide
– Fall of intracellular calcium in BV e.g. Hydralazine
28
Hydralazine Action:
VD is usually associated with:
REFLEX TACHYCARDIA # by - blockers
WATER RETENTION # Diuretics.
No Postural hypotension: Because of preferential arteriodilation.
Uses
Severe hypertension (stage 3).
Congestive heart failure. (Hydralazine + nitrates + BB + HTZ)
Hypertensive emergencies (pregnant women especially preeclampsia).
Side effects
Headache
Tachycardia and marked sodium and water retention
Diarrhea
A lupus-like syndrome may occur
29
K+ ATP Channel Openers: Minoxidil
Mechanism of hypotensive action:
• Minoxidil is a prodrug
• Therapeutic Uses of Minoxedil:
1. TTT of severe hypertension in male patients:
2. Resistant Heart failure (due to VD effect).
3. Topically in Alopecia “male pattern baldness” Adverse Effects and Precautions:
1. Fluid and salt retention # diuretics.
2. Reflex tachycardia & palpitation # BB.
3. Hypertrichosis: in face, back, arms, and legs (offensive to women) # avoided in females.
4. Hyperglycemia # avoided in DM.
30
Diazoxide (HYPERSTAT IV)
• It is long-acting arteriodilator
• insulin secretion hyperglycemia.
Uses:
1. I.V. in hypertensive emergencies if:
– Non-availability of sodium nitroprusside.
– Non-availability of infusion pump.
– Non feasible close monitoring of BP.
2. Orally in hypoglycemia associated with hyperinsulinoma.
Adverse Effects of Diazoxide:
Palpitations & tachycardia; Fluid retention; Hyperglycemia;
Gastrointestinal intolerance
31
Sodium nitroprusside (mixed dilator)
Locus and Mechanism of Action:
• It acts by releasing NO NO activates the guanylyl
cyclase cGMP VD in both arterioles & venules
both PVR & venous return BP.
• Therapeutic Uses • Short-acting agent (few minutes) thus it must be
infused continuously
1. Hypertensive emergencies (first choice).
because it has rapid onset of action, very effective and has an acceptable toxicity that can be monitored
1. Acute aortic dissection: to BP during the surgery.
2. HTN patients with cardiac asthma: to improve CO.
3. Post MI: to decrease myocardial oxygen demand.
4. To induce controlled hypotension during anesthesia.
Sodium nitroprusside (cont.) • Side effects
– Hypotension (most frequent adverse effect)
– Nausea & vomiting
– Headache
– Palpitation
– Release of cyanide ions in certain cases.
APPENDIX
07/03/2016 33
Steps of Drug Therapy for
Hypertension
1st Step → Monotherapy
Diuretics ACEI
Ca Channel Blockers β-blocker
• The drugs therapy is changed if:
(a) NO response
(b) They are poorly tolerated
(c) There is contraindication e.g. asthma
(d) There is concurrent disease that might benefit from
another class of antihypertensive drugs
If BP decreased BUT not to the recommended
level
• 2nd Step → Two Drugs
β-blockers + diuretic OR Ca antagonist
OR
ACEI + diuretic OR Ca antagonist
• If failed → 3 drugs
• If failed → Resistant hypertension (give 4 or 5
drugs including vasodilators)
Pregnant Women
Pre-existing chronic hypertension
Give only methyl dopa, Nifedipine OR Labetalol
Other drugs are teratogenic
Diuretics, β-blockers & ACEI retard fetal growth in the 2nd trimester
Pre-eclampsia After 20 weeks of gestation
Hypertension, edema, protein urea & hyperuricemia
Fetal death or growth retardation
Bed rest
In severe case, give iv bolus injection of hydralzine
Then methyl dopa, Nifedipine OR labetalol
Treatment of Hypertensive Emergencies
• Hypertensive emergencies (with end organ damag) include
hypertension associated with vascular damage (termed malignant
hypertension) and hypertension associated with hemodynamic
complications such as heart failure, stroke, or dissecting aortic aneurysm
• The goal of treatment in the first few hours or days is to lower BP by
about 25%, maintaining diastolic blood pressure at no less than 100 mm
Hg. Subsequently, blood pressure can be reduced to normal levels using
oral medications over several weeks.
• Complete normalization of blood pressure at first is contraindicated
because rapid normalization of blood pressure may lead to cerebral
hypoperfusion and brain injury.
Treatment of Hypertensive Emergencies
• Sodium nitroprusside (most common FIRST CHOICE).
• Other parenteral drugs e.g. fenoldopam, nitroglycerin,
labetalol, calcium channel blockers, diazoxide, and
hydralazine.
• Esmolol is often used to manage intraoperative and
postoperative hypertension.
• Diuretics such as furosemide are administered during
administration of powerful vasodilators
07/03/2016 40
TTT of hypertensive urgency
HTN urgency: HTN crisis without end organ damage
• Need prompt medical attention BUT lowering BP
can be achieved within 24-48 h.
• Use vigorous oral therapy in outpatient clinic.
• e.g., Captopril & clonidine Can be used for
treatment of HTN urgency.
07/03/2016 41
Choice of Antihypertensive Drugs
1. Uncomplicated stage 1 HTN.
2. Uncomplicated stage 2 HTN.
3. HTN with heart failure.
4. HTN + pregnancy
5. Isolated syst HTN
6. HTN emergency
1. HTZ Diuretics or Bs, ACEIs / AIIRBs, CCBs (or combination)
2. HTZ Diuretics + another drugs from any class.
3. ACEIs / AIIRBs + Diuretic, Bs,
4. -methydopa or Hydralazine
5. CCBs (Amlodipine).
6. I.V. Na nitroprusside,
07/03/2016 42
Summary of most important contraindications of
antihypertensive drugs
• CCBs (verapamil & diltiazem) in HTN with HF or
heart block.
• BBs in HTN with peripheral vascular disease.
• BBs and ACEIs in HTN with BA or COPD.
• Diuretics, BBs, ACEIs or AIIRBs in HTN with
pregnancy.
• BBs, Diuretics & diazoxide in HTN with diabetes.
• Thiazides, BBs and sympatholytics in HTN with
impotence.
LETURE RESOURCES: • Harvey R. A. (2015). Lippincott's Illustrated Reviews:
Pharmacology. 5th ed., Philadelphia, PA, USA,
Lippincott Williams& Wilkins. Unite IV; chapter 19.
• Katzung B.G. (2015), Basic and Clinical
Pharmacology, 13 th ed., New York, USA, McGraw-
Hill Medical. Section III; chapter 11.
07/03/2016 43